Advertisement

Metabolic syndrome and nephrolithiasis; a cross sectional population-based study on the baseline data of the PERSIAN Kavar cohort study

Published:November 23, 2022DOI:https://doi.org/10.1016/j.urology.2022.11.004

      Abstract

      Objective

      To explore the relationship between metabolic syndrome and its components with nephrolithiasis.

      Methods

      In current study, 4,901 individuals from the PERSIAN (Prospective Epidemiological Research Studies in IrAN) Kavar cohort study were included. Metabolic syndrome was defined according to the ATP III criteria (2005 revision). The nephrolithiasis was assessed using a structured questionnaire, and ultrasound findings were reviewed in subjects who reported positive history of nephrolithiasis. We applied logistic regression to estimate the odds ratio (OR) and 95% confidence interval (CI).

      Results

      The prevalence of nephrolithiasis and metabolic syndrome was 28.5% and 40.91%, respectively. Almost 31% of the patients with metabolic syndrome had a history of nephrolithiasis. Multivariable logistic regression analysis revealed a positive association between metabolic syndrome and nephrolithiasis (OR= 1.30, 95% CI: 1.14-1.49, P <0.001) after adjustment age, sex, ethnicity, physical activity, smoking status, and alcohol intake. Furthermore, the relation was higher for elders aged 50 years or more (P for interaction= 0.016) and Turk Nomad participants (P for interaction= 0.044) than the others. There was also a positive independent association between hypertension (OR=1.29, 95% CI: 1.12-1.48, P<0.001) and hypertriglyceridemia (OR= 1.15, 95% CI: 1.01-1.31, P=0.033) with nephrolithiasis.

      Conclusions

      In this large sample study, we demonstrate a weak positive association between metabolic syndrome, hypertension, and hypertriglyceridemia with nephrolithiasis.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Urology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. Nojaba L, Guzman N. Nephrolithiasis. [Updated 2021 Aug 11]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK559227/?report=classic.

        • Bensalah K
        • Tuncel A
        • Gupta A
        • Raman JD
        • Pearle MS
        • Lotan Y
        Determinants of quality of life for patients with kidney stones.
        J Urol. 2008; 179: 2238-2243https://doi.org/10.1016/j.juro.2008.01.116
        • Romero V
        • Akpinar H
        • Assimos DG.
        Kidney stones: a global picture of prevalence, incidence, and associated risk factors.
        Rev Urol. 2010; 12: e86-e96
      2. Swarup S, Goyal A, Grigorova Y, et al Metabolic Syndrome [Updated 2022 May 2] In: StatPearls [Internet] Treasure Island (FL): StatPearls Publishing; 2022 Jan- Available from: https://wwwncbinlmnihgov/books/NBK459248/.

        • Grundy SM
        • Cleeman JI
        • Daniels SR
        • Donato KA
        • Eckel RH
        • Franklin BA
        • et al.
        Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement.
        Circulation. 2005; 112: 2735-2752
        • Saklayen MG.
        The Global Epidemic of the Metabolic Syndrome.
        Curr Hypertens Rep. 2018; 20: 12https://doi.org/10.1007/s11906-018-0812-z
        • Besiroglu H
        • Otunctemur A
        • Ozbek E.
        The metabolic syndrome and urolithiasis: a systematic review and meta-analysis.
        Ren Fail. 2015; 37: 1-6https://doi.org/10.3109/0886022X.2014.976133
        • Chang CW
        • Ke HL
        • Lee JI
        • Lee YC
        • Jhan JH
        • Wang HS
        • et al.
        Metabolic Syndrome Increases the Risk of Kidney Stone Disease: A Cross-Sectional and Longitudinal Cohort Study.
        J Pers Med. 2021; 11: 1154https://doi.org/10.3390/jpm11111154
        • Geraghty RM
        • Cook P
        • Roderick P
        • Somani B.
        Risk of Metabolic Syndrome in Kidney Stone Formers: A Comparative Cohort Study with a Median Follow-Up of 19 Years.
        J Clin Med. 2021; 10: 978https://doi.org/10.3390/jcm10050978
        • Wu B
        • Xie J
        • Guo J
        • Wang J
        • Lang H.
        Association between metabolic syndrome and calcium oxalate stone risk in Chinese individuals: a nomogram prediction model.
        J Int Med Res. 2021; 490300060520986726
        • Masterson JH
        • Woo JR
        • Chang DC
        • Chi T
        • L'Esperance JO
        • Stoller ML
        • et al.
        Dyslipidemia is associated with an increased risk of nephrolithiasis.
        Urolithiasis. 2015; 43: 49-53
        • Safarpour AR
        • Fattahi MR
        • Niknam R
        • Tarkesh F
        • Mohammadkarimi V
        • Boogar SS
        • et al.
        Alarm of non-communicable disease in Iran: Kavar cohort profile, baseline and 18-month follow up results from a prospective population-based study in urban area.
        PLoS One. 2022; 17e0260227https://doi.org/10.1371/journal.pone.0260227
        • Chalasani N
        • Younossi Z
        • Lavine JE
        • Diehl AM
        • Brunt EM
        • Cusi K
        • et al.
        The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology.
        Gastroenterology. 2012; 142: 1592-1609
        • Ghafouri M
        • Teymourzadeh A
        • Nakhostin-Ansari A
        • Sepanlou SG
        • Dalvand S
        • Moradpour F
        • et al.
        Prevalence and predictors of low back pain among the Iranian population: Results from the Persian cohort study.
        Ann Med Surg (Lond). 2022; 10103243https://doi.org/10.1016/j.amsu.2022.103243
        • Kazemi Karyani A
        • Karmi Matin B
        • Soltani S
        • Rezaei S
        • Soofi M
        • Salimi Y
        • et al.
        Socioeconomic gradient in physical activity: findings from the PERSIAN cohort study.
        BMC Public Health. 2019; 19: 1312https://doi.org/10.1186/s12889-019-7715-z
        • Eghtesad S
        • Mohammadi Z
        • Shayanrad A
        • Faramarzi E
        • Joukar F
        • Hamzeh B
        • et al.
        The PERSIAN Cohort: Providing the Evidence Needed for Healthcare Reform.
        Arch Iran Med. 2017; 20: 691-695
        • Maher JM
        • Markey JC
        • Ebert-May D.
        The other half of the story: effect size analysis in quantitative research.
        CBE Life Sci Educ. 2013; 12: 345-351https://doi.org/10.1187/cbe.13-04-0082
        • Liu YT
        • Yang PY
        • Yang YW
        • Sun HY
        • Lin IC.
        The association of nephrolithiasis with metabolic syndrome and its components: a cross-sectional analysis.
        Ther Clin Risk Manag. 2017; 13: 41-48https://doi.org/10.2147/tcrm.S125480
        • Wu B
        • Xie J
        • Guo J
        • Wang J
        • Lang H.
        Association between metabolic syndrome and calcium oxalate stone risk in Chinese individuals: a nomogram prediction model.
        J Int Med Res. 2021; 490300060520986726https://doi.org/10.1177/0300060520986726
        • Hartman C
        • Friedlander JI
        • Moreira DM
        • Leavitt DA
        • Hoenig DM
        • Smith AD
        • et al.
        Does hypertension impact 24-hour urine parameters in patients with nephrolithiasis?.
        Urology. 2015; 85: 539-543
        • Kohjimoto Y
        • Sasaki Y
        • Iguchi M
        • Matsumura N
        • Inagaki T
        • Hara I.
        Association of metabolic syndrome traits and severity of kidney stones: results from a nationwide survey on urolithiasis in Japan.
        Am J Kidney Dis. 2013; 61: 923-929https://doi.org/10.1053/j.ajkd.2012.12.028
        • Hopps E
        • Noto D
        • Caimi G
        • Averna MR.
        A novel component of the metabolic syndrome: the oxidative stress.
        Nutr Metab Cardiovasc Dis. 2010; 20: 72-77https://doi.org/10.1016/j.numecd.2009.06.002
        • Sharma P.
        Inflammation and the metabolic syndrome.
        Springer, 2011: 317-318
        • Wigner P
        • Grebowski R
        • Bijak M
        • Szemraj J
        • Saluk-Bijak J.
        The Molecular Aspect of Nephrolithiasis Development.
        Cells. 2021; 10: 1926https://doi.org/10.3390/cells10081926
        • Liu S
        • Song Y
        • Ford ES
        • Manson JE
        • Buring JE
        • Ridker PM.
        Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older US women.
        Diabetes Care. 2005; 28: 2926-2932https://doi.org/10.2337/diacare.28.12.2926
        • Ferraro PM
        • Bargagli M
        • Trinchieri A
        • Gambaro G.
        Risk of kidney stones: influence of dietary factors, dietary patterns, and vegetarian–vegan diets.
        Nutrients. 2020; 12: 779https://doi.org/10.3390/nu12030779
        • Takase H
        • Machii M
        • Nonaka D
        • Ohno K
        • Takayama S
        • Sugiura T
        • et al.
        Excessive salt intake is a significant predictor for future development of metabolic syndrome in the general population.
        European Heart Journal. 2020; 41 (3058): ehaa946https://doi.org/10.1093/ehjci/ehaa946.3058
        • Kim Y
        • Je Y.
        Meat Consumption and Risk of Metabolic Syndrome: Results from the Korean Population and a Meta-Analysis of Observational Studies.
        Nutrients. 2018; 10: 390https://doi.org/10.3390/nu10040390
        • Obligado SH
        • Goldfarb DS.
        The association of nephrolithiasis with hypertension and obesity: a review.
        Am J Hypertens. 2008; 21: 257-264https://doi.org/10.1038/ajh.2007.62
        • Torricelli FC
        • De SK
        • Gebreselassie S
        • Li I
        • Sarkissian C
        • Monga M.
        Dyslipidemia and kidney stone risk.
        J Urol. 2014; 191: 667-672https://doi.org/10.1016/j.juro.2013.09.022
        • Kittanamongkolchai W
        • Mara KC
        • Mehta RA
        • Vaughan LE
        • Denic A
        • Knoedler JJ
        • et al.
        Risk of hypertension among first-time symptomatic kidney stone formers.
        Clin J Am Soc Nephrol. 2017; 12: 476-482https://doi.org/10.2215/CJN.06600616
        • Chung SD
        • Chen YK
        • Lin HC.
        Increased risk of diabetes in patients with urinary calculi: a 5-year followup study.
        J Urol. 2011; 186: 1888-1893https://doi.org/10.1016/j.juro.2011.07.011
        • Khalili P
        • Jamali Z
        • Sadeghi T
        • Esmaeili-Nadimi A
        • Mohamadi M
        • Moghadam-Ahmadi A
        • et al.
        Risk factors of kidney stone disease: a cross-sectional study in the southeast of Iran.
        BMC Urol. 2021; 21: 141https://doi.org/10.1186/s12894-021-00905-5
        • Naghipour M
        • Joukar F
        • Nikbakht H-A
        • Hassanipour S
        • Asgharnezhad M
        • Arab-Zozani M
        • et al.
        High prevalence of metabolic syndrome and its related demographic factors in North of Iran: results from the Persian Guilan cohort study.
        Int J Endocrinol. 2021; 8862456https://doi.org/10.1155/2021/8862456
        • Farmanfarma KK
        • Kaykhaei MA
        • Adineh HA
        • Mohammadi M
        • Dabiri S
        • Ansari-Moghaddam A.
        Prevalence of metabolic syndrome in Iran: A meta-analysis of 69 studies.
        Diabetes Metab Syndr. 2019; 13: 792-799https://doi.org/10.1016/j.dsx.2018.11.055